| Clinical aspects of autoimmune rheumatic diseases F Goldblatt, SG O'Neill The Lancet 382 (9894), 797-808, 2013 | 283 | 2013 |
| Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality F Goldblatt, S Chambers, A Rahman, DA Isenberg Lupus 18 (8), 682-689, 2009 | 210 | 2009 |
| Antibody-mediated gastrointestinal dysmotility in scleroderma F Goldblatt, TP Gordon, SA Waterman Gastroenterology 123 (4), 1144-1150, 2002 | 160 | 2002 |
| New therapies for rheumatoid arthritis F Goldblatt, DA Isenberg Clinical & Experimental Immunology 140 (2), 195-204, 2005 | 145 | 2005 |
| Impaired Opsonization with C3b and Phagocytosis of Streptococcus pneumoniae in Sera from Subjects with Defects in the Classical Complement Pathway J Yuste, A Sen, L Truedsson, G Jönsson, LS Tay, C Hyams, ... Infection and immunity 76 (8), 3761-3770, 2008 | 135 | 2008 |
| Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study V Golder, R Kandane-Rathnayake, AYB Hoi, M Huq, W Louthrenoo, Y An, ... Arthritis research & therapy 19, 1-11, 2017 | 134 | 2017 |
| Sjögren's Systemic Clinical Activity Index (SCAI)—a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome SJ Bowman, N Sutcliffe, DA Isenberg, F Goldblatt, M Adler, E Price, ... Rheumatology 46 (12), 1845-1851, 2007 | 104 | 2007 |
| Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health PL Dobkin, D Da Costa, M Dritsa, PR Fortin, JL Senécal, JR Goulet, ... Arthritis Care & Research 12 (6), 401-410, 1999 | 104 | 1999 |
| Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study V Golder, R Kandane-Rathnayake, M Huq, HT Nim, W Louthrenoo, ... The Lancet Rheumatology 1 (2), e95-e102, 2019 | 95 | 2019 |
| New therapies for systemic lupus erythematosus F Goldblatt, DA Isenberg Clinical & Experimental Immunology 140 (2), 205-212, 2005 | 79 | 2005 |
| Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal … SM Proudman, HI Keen, LK Stamp, ATY Lee, F Goldblatt, OC Ayres, ... Seminars in arthritis and rheumatism 37 (2), 99-111, 2007 | 77 | 2007 |
| The Sjögren's Syndrome Damage Index—a damage index for use in clinical trials and observational studies in primary Sjögren's syndrome RJ Barry, N Sutcliffe, DA Isenberg, E Price, F Goldblatt, M Adler, ... Rheumatology 47 (8), 1193-1198, 2008 | 73 | 2008 |
| Estimating indirect costs in primary Sjögren’s syndrome SJ Bowman, YS Pierre, N Sutcliffe, DA Isenberg, F Goldblatt, E Price, ... The Journal of rheumatology 37 (5), 1010-1015, 2010 | 67 | 2010 |
| Association of Kikuchi–Fujimoto's disease with SLE F Goldblatt, J Andrews, A Russell, D Isenberg Rheumatology 47 (4), 553-554, 2008 | 66 | 2008 |
| Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort V Golder, R Kandane-Rathnayake, AYB Hoi, M Huq, W Louthrenoo, Y An, ... Arthritis research & therapy 18, 1-9, 2016 | 57 | 2016 |
| Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study D Apostolopoulos, R Kandane-Rathnayake, W Louthrenoo, SF Luo, ... The Lancet Rheumatology 2 (1), e24-e30, 2020 | 55 | 2020 |
| Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study V Golder, R Kandane-Rathnayake, M Huq, W Louthrenoo, SF Luo, ... The Lancet Rheumatology 1 (2), e103-e110, 2019 | 49 | 2019 |
| Systemic lupus erythematosus: 2006 update M Petri JCR: Journal of Clinical Rheumatology 12 (1), 37-40, 2006 | 47 | 2006 |
| A clinician's pearls and myths in rheumatology JH Stone Springer 2009, 54, 2009 | 43 | 2009 |
| Development of the Asia Pacific lupus collaboration cohort R Kandane‐Rathnayake, V Golder, W Louthrenoo, SF Luo, YJ Jan Wu, ... International journal of rheumatic diseases 22 (3), 425-433, 2019 | 33 | 2019 |
